Big pharma has an interest in rich people being sick | Giles Fraser
What profit is there in a healthy population? If everyone were healthy, it would be the job of the pharmaceutical companies to persuade us that we were not well
The giant pharmaceutical company GlaxoSmithKline said yesterday that its work on a vaccine for Ebola will come too late to do anything about the current situation. Even now it is trying to compress trials that would normally take a decade into a year. The impression it gives is that it is working flat out, no holds barred. But hang on a moment. Ebola was discovered back in 1976. What has GlaxoSmithKline been doing since then? Answer: not much.
A small clue to why can be found by looking at the stock price of Tekmira Pharmaceuticals, the Canadian-based drugs firm that some investors seem to think is leading the pack on Ebola research. Tekmira shares rose a massive 180% from mid-July to October, with most of the share-price action coming when the virus jumped to Europe and the US.
More From Around the Web
Check out these Articles
- Disease resistance to antibiotics at tipping point, expert warns
- Is the failure of health regulation damaging our well-being? | Aseem Malhot...
- Naloxone Available in Some Pennsylvania Pharmacies Under Statewide Standing...
- Government spent further £49m on Tamiflu despite known doubts about it
- Pfizer AstraZeneca takeover attempt prompts job warning from Vince Cable
- Forum for Drug Sponsors and Contract Development and Manufacturing Professi...
- Lord Sainsbury calls for government to stop Pfizer buying AstraZeneca
- Michael White’s diary: AstraZeneca beware those asset strippers haven...
- AbbVie should raise the stakes in courting Shire